Discover
PRCT
PROCEPT BioRobotics Corporation
22.89
1 x 22.22
1 x 23.00
bid
ask
+
1.18
5.44%
214 @ 04:00 PM
22.89 +0.00 (0.00%)
| Ytd | -27.24% | |
| 1y | -40.96% |
21.20
day range
22.92
16.66
52 week range
42.70
| Open | 21.38 | Prev Close | 21.71 | Low | 21.20 | High | 22.92 | Mkt Cap | 1.30B |
| Vol | 0.00 | Avg Vol | 1.73M | EPS | -1.94 | P/E | -11.80 | Forward P/E | -17.71 |
| Beta | 0.89 | Short Ratio | 4.15 | Inst. Own | 102.97% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 21.70 | 200-d Avg | 27.11 | 1yr Est | 21.64 |
| Income Statement | |||
| Total Revenue | 94.50M | ||
| Revenues (USD) | 94.50M | ||
| Cost of Revenue | 32.12M | ||
| Gross Profit | 62.38M | ||
| Operating Expenses | 89.77M | ||
| Research and Development Expense | 20.10M | ||
| Selling, General and Administrative Expense | 69.67M | ||
| Operating Income | -27.39M | ||
| Interest Expense | 842.00K | ||
| Income Tax Expense | 94.00K | ||
| Net Income | -26.86M | ||
| Net Income Common Stock | -26.86M | ||
| Net Income Common Stock (USD) | -26.86M | ||
| Consolidated Income | -26.86M | ||
| Earnings per Basic Share | -0.47 | ||
| Earnings per Basic Share (USD) | -0.47 | ||
| Earnings per Diluted Share | -0.47 | ||
| Earning Before Interest & Taxes (EBIT) | -25.92M | ||
| Earning Before Interest & Taxes (USD) | -25.92M | ||
| Weighted Average Shares | 57.07M | ||
| Weighted Average Shares Diluted | 57.07M | ||
| Balance Sheet | |||
| Cash and Equivalents | 227.91M | ||
| Cash and Equivalents (USD) | 227.91M | ||
| Investments | 3.04M | ||
| Investments Non-Current | 3.04M | ||
| Trade and Non-Trade Receivables | 107.61M | ||
| Current Assets | 420.29M | ||
| Property, Plant & Equipment Net | 48.61M | ||
| Total Assets | 479.35M | ||
| Debt Current | 2.51M | ||
| Total Debt | 77.50M | ||
| Current Liabilities | 64.20M | ||
| Debt Non-Current | 75.00M | ||
| Total Liabilities | 139.28M | ||
| Accumulated Retained Earnings (Deficit) | -700.06M | ||
| Accumulated Other Comprehensive Income | 22.00K | ||
| Shareholders Equity | 340.07M | ||
| Shareholders Equity (USD) | 340.07M | ||
| Assets Non-Current | 59.07M | ||
| Total Debt (USD) | 77.50M | ||
| Deferred Revenue | 14.09M | ||
| Goodwill and Intangible Assets | 571.00K | ||
| Inventory | 77.06M | ||
| Liabilities Non-Current | 75.09M | ||
| Trade and Non-Trade Payables | 15.07M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.83M | ||
| Net Cash Flow from Financing | 4.50M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -17.73M | ||
| Capital Expenditure | -2.95M | ||
| Issuance (Purchase) of Equity Shares | 4.50M | ||
| Net Cash Flow from Investing | -2.95M | ||
| Net Cash Flow from Operations | -19.25M | ||
| Effect of Exchange Rate Changes on Cash | -20.00K | ||
| Share Based Compensation | 14.53M | ||